Hideto Ueki

18PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMedical roboticsCancer therapy (excl. chemotherapy and radiation therapy)Context learningCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 20, 2026
Efficacy and Safety of Enfortumab Vedotin by Trial Eligibility in Advanced Urothelial Carcinoma: A Multicenter Real-World Study.

|Jul 22, 2026
Effects of Modifying Hinotori Surgical Robot System on the Learning Curve of Robot-Assisted Radical Prostatectomy.

|Jul 19, 2026
Prognostic Significance of the Modified Glasgow Prognostic Score and Systemic Immune-Inflammation Index in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Cabazitaxel.

|Mar 24, 2026
The Impact of the Relevant Factors as High-Complexity Tumors in Robot-Assisted Partial Nephrectomy.

Jun Teishima, Takuto Hara, Hideto Ueki

|Mar 14, 2026
Real-World Safety and Early Effectiveness of First-Line Enfortumab Vedotin Plus Pembrolizumab with Routine Dexamethasone Premedication in Advanced Urothelial Carcinoma.

Takuto Hara, Naoto Wakita, Taisuke Tobe

|Feb 11, 2026
Risk stratification by pathological upstaging and tumor necrosis in clinical T1 clear-cell renal cell carcinoma: evidence from a multi-institutional cohort of 1081 patients.

Hideto Ueki, Takuto Hara, Taisuke Tobe

Pageof 3

Frequent Collaborators

12 joint publications

Tomoaki Terakawa

11 joint publications

Takuto Hara

10 joint publications

Kotaro Suzuki

5 joint publications

Jun Teishima